@article{651a0d398668423c8feaa1a1ec4082b0,
title = "Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics",
keywords = "ASCVD, CVOT, GLP-1 RA, cardiovascular, type 2 diabetes",
author = "Ildiko Lingvay and Aroda, {Vanita R.} and Honor{\'e}, {Julie Broe} and Ersb{\o}ll, {Anne S.} and {Nystrup Husemoen}, {Lise Lotte} and Jensen, {Anders Boeck} and {Sommer Matthiessen}, Kasper and Kosiborod, {Mikhail Naum}",
note = "Funding Information: Medical writing and editorial support were provided by Alice Garrett, Malgorzata Urbacz, and Izabel James, of Ashfield MedComms, an Inizio company, funded by Novo Nordisk A/S. Further Novo Nordisk staff contributed to this work: Shahzleen Rajan participated in planning and interpretation; Akasha Strub assisted with gathering data; Mads Reinholdt S{\o}rensen caried out review of the code for data gathering and analysis; and Dina Graae Kristensen and Rishibha Sachdev participated in planning and coordination of the work. This study was supported by Novo Nordisk A/S. ",
year = "2023",
month = feb,
doi = "10.1111/1753-0407.13363",
language = "English (US)",
volume = "15",
pages = "190--195",
journal = "Journal of Diabetes",
issn = "1753-0393",
publisher = "Wiley-Blackwell",
number = "2",
}